EGI
FLGT icon

EAM Global Investors’s Fulgent Genetics FLGT Stock Holding History

EAM Global Investors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,558
Closed -$1.22M – 145
2020
Q3 		$1.22M Buy
+30,558
New +$957K 0.45% 108
2020
Q2 		– Sell
-120,232
Closed -$1.29M – 130
2020
Q1 		$1.29M Sell
120,232
-3,438
-3% -$47.9K 0.76% 68
2019
Q4 		$1.59M Buy
+123,670
New +$1.47M 0.64% 89

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

EAM Global Investors's FLGT Position: Q4 2020 in Review

EAM Global Investors sold out of Fulgent Genetics (FLGT) in Q4 2020, closing a stake of 30,558 shares — an estimated $1.22M sold.

EAM Global Investors first reported a position in FLGT in Q4 2019 and held it in 3 quarters. The position peaked at $1.59M in Q4 2019. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2020.

  • EAM Global Investors reported no remaining Fulgent Genetics position as of Q4 2020 after selling out during the quarter.
  • EAM Global Investors sold 30,558 Fulgent Genetics shares in Q4 2020, an estimated $1.22M.
  • EAM Global Investors first reported a position in Fulgent Genetics in Q4 2019 and held it in 3 quarters.
  • EAM Global Investors's Fulgent Genetics position peaked at $1.59M in Q4 2019.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2020.

Based on EAM Global Investors's 13F filing for Q4 2020, filed 11 Feb 2021.